Trial intelligence / Profile preview

Aranesp in preterm infants

NCT00334737Phase 2Completed

Sponsor
The University of New Mexico
Start
Jun 2006
Primary completion
Dec 2013
Countries
1
01

Overview

A Phase 2 trial of darbepoetin alfa in anemia of prematurity (AOP), sponsored by The University of New Mexico. Started Jun 2006; status: completed.

02

Drugs

darbepoetin alfa
03

Conditions

anemia of prematurity (AOP)

Beyond the preview

Go deeper on NCT00334737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00334737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call